A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts

• Главные авторы: Michael D. Schultz (Автор), John J. Suschak (Автор), Davide Botta (Автор), Aaron Silva-Sanchez (Автор), R. Glenn King (Автор), Thomas W. Detchemendy (Автор), Chetan D. Meshram (Автор), Jeremy B. Foote (Автор), Fen Zhou (Автор), Jennifer L. Tipper (Автор), Jianfeng Zhang (Автор), Kevin S. Harrod (Автор), Sixto M. Leal (Автор), Troy D. Randall (Автор), M. Scot Roberts (Автор), Bertrand Georges (Автор), Frances E. Lund (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

The coronavirus disease 2019 (COVID-19) pandemic has illustrated the critical need for effective prophylactic vaccination to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Intranasal vaccination is an attractive approach for preventing COVID-19 as the nasal mucos...